Does SECUKINUMAB Cause Deafness bilateral? 16 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Deafness bilateral have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.0% of all adverse event reports for SECUKINUMAB.
16
Reports of Deafness bilateral with SECUKINUMAB
0.0%
of all SECUKINUMAB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Deafness bilateral From SECUKINUMAB?
Of the 16 reports, 3 (18.8%) required hospitalization, and 1 (6.3%) were considered life-threatening.
Is Deafness bilateral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Deafness bilateral?
ADALIMUMAB (59)
AMIKACIN (36)
CISPLATIN (36)
CLARITHROMYCIN (36)
METHOTREXATE (30)
VANCOMYCIN (26)
AZITHROMYCIN (24)
CARBOPLATIN (24)
DEXAMETHASONE (23)
FUROSEMIDE (23)
Which SECUKINUMAB Alternatives Have Lower Deafness bilateral Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG